LJPC
Price:
$6.19
Market Cap:
$0
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic ...[Read more]
Industry
Biotechnology
IPO Date
1994-06-03
Stock Exchange
NASDAQ
Ticker
LJPC
According to La Jolla Pharmaceutical Company’s latest financial reports and current stock price. The company's current Enterprise Value is -44025000.00. This represents a change of -164.86% compared to the average of 67.88M of the last 4 quarters.
The mean historical Enterprise Value of La Jolla Pharmaceutical Company over the last ten years is 158.11M. The current -44025000.00 Enterprise Value has changed -2884.48% with respect to the historical average. Over the past ten years (40 quarters), LJPC's Enterprise Value was at its highest in in the September 2017 quarter at 648.67M. The Enterprise Value was at its lowest in in the September 2013 quarter at -3997412.00.
Average
158.11M
Median
100.13M
Minimum
-4948870.30
Maximum
591.78M
Discovering the peaks and valleys of La Jolla Pharmaceutical Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 182.27%
Maximum Annual Enterprise Value = 591.78M
Minimum Annual Increase = -3095.66%
Minimum Annual Enterprise Value = -4948870.30
| Year | Enterprise Value | Change |
|---|---|---|
| 2021 | 114.91M | 34.63% |
| 2020 | 85.35M | 77.90% |
| 2019 | 47.98M | -28.53% |
| 2018 | 67.13M | -88.66% |
| 2017 | 591.78M | 150.46% |
| 2016 | 236.28M | -20.21% |
| 2015 | 296.11M | 99.74% |
| 2014 | 148.25M | -3095.66% |
| 2013 | -4948870.30 | 182.27% |
| 2012 | -1753248.00 | -64.80% |
The current Enterprise Value of La Jolla Pharmaceutical Company (LJPC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
82.75M
5-year avg
181.43M
10-year avg
158.11M
La Jolla Pharmaceutical Company’s Enterprise Value is less than F-star Therapeutics, Inc. (91.20M), less than eXoZymes, Inc. (119.95M), less than Paratek Pharmaceuticals, Inc. (351.99M), less than Pardes Biosciences, Inc. (75.90M), less than Selecta Biosciences, Inc. (-11774246.00), less than aTyr Pharma, Inc. (81.68M), less than NGM Biopharmaceuticals, Inc. (69.72M), less than Theseus Pharmaceuticals, Inc. (90.87M), less than Sesen Bio, Inc. (127.66M), less than LENZ Therapeutics, Inc. (469.74M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 91.20M | $156.51M | |
| 119.95M | $124.05M | |
| 351.99M | $127.83M | |
| 75.90M | $135.19M | |
| -11774246.00 | $135.20M | |
| 81.68M | $75.47M | |
| 69.72M | $128.53M | |
| 90.87M | $181.50M | |
| 127.66M | $127.96M | |
| 469.74M | $506.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like La Jolla Pharmaceutical Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like La Jolla Pharmaceutical Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is La Jolla Pharmaceutical Company's Enterprise Value?
What is the highest Enterprise Value for La Jolla Pharmaceutical Company (LJPC)?
What is the 3-year average Enterprise Value for La Jolla Pharmaceutical Company (LJPC)?
What is the 5-year average Enterprise Value for La Jolla Pharmaceutical Company (LJPC)?
How does the current Enterprise Value for La Jolla Pharmaceutical Company (LJPC) compare to its historical average?